Healthcare · NIFTY 500

Poly Medicure Limited

NSEPOLYMED BSE531768 ISININE205C01021 SeriesEQ Listed on NSE · BSE · MSEI

₹1,693.10 +19.70 (+1.18%) Updated 12 Nov, 8:49 pm IST

Open chart Back to screener

Price, daily close-17.15% in a year

Today

Open: ₹1,676.60
Prev close: ₹1,673.40
Day high: ₹1,705.60
Day low: ₹1,660.30
Volume: 83.7 K
Value traded: ₹14.15 Cr
Upper circuit: ₹2,008.00
Lower circuit: ₹1,338.80
52W high: ₹2,094.30
52W low: ₹1,182.00
1 month: +0.92%
6 months: -1.87%

52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹17,161 Cr

P/E (TTM)53.97

P/B5.26

Book value / share₹322.15

EPS (TTM)₹31.37

ROE9.8%

Dividend yield0.21%

Dividend (12m)₹3.50 / share

Net margin (TTM)14.9%

Operating margin25.3%

Debt / equity0.12

Current ratio3.13

EV / EBITDA35.91

Sales growth (YoY qtr)+30.78%

Profit growth (YoY qtr)+3.59%

Sales CAGR 3Y+18.91%

Profit CAGR 3Y+21.57%

Shares10.14 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

34065.0

Dec 23

37868.4

Mar 24

38574.0

Jun 24

42087.5

Sep 24

42485.2

Dec 24

44191.8

Mar 25

40393.1

Jun 25

44491.8

Sep 25

49470.9

Dec 25

53566.3

Mar 26

52586.0

Jun 26

58195.1

Sep 26

Revenue · QoQ (vs last quarter)

—+11%+1.8%+9.2%+1.0%+3.9%-8.5%+10%+11%+8.3%-1.7%+10%

Revenue · YoY (vs a year ago)

————+25%+17%+4.8%+5.7%+16%+21%+30%+31%

Net profit · QoQ (vs last quarter)

—+5.1%+8.3%+18%-2.5%+7.8%+1.4%-1.3%-23%-6.5%+30%+11%

Net profit · YoY (vs a year ago)

————+31%+34%+26%+5.0%-17%-28%-7.6%+3.6%

RevenueNet profitLine = trend

6.77

Dec 23

7.12

Mar 24

7.71

Jun 24

9.01

Sep 24

8.48

Dec 24

8.92

Mar 25

9.17

Jun 25

9.06

Sep 25

6.99

Dec 25

6.53

Mar 26

8.48

Jun 26

9.37

Sep 26

EPS (₹) · YoY (vs a year ago)

————+25%+25%+19%+0.6%-18%-27%-7.5%+3.4%

EPS (₹)Line = trend

₹ Cr	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26	Sep 26
Revenue	340	378	385	420	424	441	403	444	494	535	525	581
Other income	16.6	15.0	16.9	26.1	21.8	24.3	41.7	33.9	26.3	17.8	33.4	19.0
Total income	356	393	402	446	446	465	445	478	520	552	559	600
Raw material	119	127	133	155	142	142	141	157	146	155	184	202
Purchases	1.1	1.4	0.9	1.2	3.3	2.5	0.9	1.2	1.6	1.4	2.7	1.6
Employee cost	60.4	69.4	70.8	78.1	77.9	78.9	75.1	88.8	115	126	127	130
Other expenses	70.9	80.8	81.8	94.1	85.3	95.1	94.7	105	112	120	134	139
Total expenses	269	301	304	329	335	345	323	357	417	469	443	485
Operating profit	90.2	96.6	104	115	115	119	106	115	104	110	125	147
OPM %	26.6%	25.5%	27.0%	27.5%	27.0%	27.1%	26.3%	25.8%	21.1%	20.7%	23.8%	25.3%
Finance cost	3.5	3.1	3.2	3.3	3.3	2.2	3.0	3.0	6.0	6.4	6.5	7.1
Depreciation	16.2	16.2	19.6	20.9	21.5	21.0	23.3	24.9	28.8	38.2	36.3	35.0
Exceptional items	—	—	—	—	—	—	—	—	-6.8	—	—	9.6
Profit before tax	87.1	92.2	98.0	117	112	121	122	121	95.9	83.5	116	124
Tax	22.8	24.1	24.4	30.5	28.0	31.0	29.9	29.9	26.8	20.2	32.0	30.3
Net profit	65.0	68.4	74.0	87.5	85.2	91.8	93.1	91.8	70.8	65.0	85.3	95.1
Profit to shareholders	65.0	68.4	74.0	87.5	85.2	91.8	93.1	91.8	70.9	66.3	86.0	95.1
EPS (₹)	6.77	7.12	7.71	9.01	8.48	8.92	9.17	9.06	6.99	6.53	8.48	9.37

Profit & loss

Results for each year

8 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

6111310.0

FY19

6871640.0

FY20

786214136

FY21

923213147

FY22

1,115265179

FY23

1,376358258

FY24

1,670453339

FY25

1,875436322

FY26

Revenue · YoY (vs a year ago)

—+13%+14%+17%+21%+23%+21%+12%

Net profit · YoY (vs a year ago)

———+7.8%+22%+44%+31%-4.8%

RevenueOperating profitNet profitLine = trend

₹ Cr	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	611	687	786	923	1,115	1,376	1,670	1,875
Other income	18.3	18.5	18.4	37.9	36.2	58.7	89.1	120
Total expenses	530	582	628	768	916	1,093	1,312	1,567
Employee cost	117	139	142	164	203	246	302	402
Operating profit	131	164	214	213	265	358	453	436
OPM %	21.4%	23.9%	27.3%	23.1%	23.8%	26.0%	27.1%	23.2%
Finance cost	11.8	18.3	8.5	4.3	8.8	11.3	12.0	18.3
Depreciation	37.3	40.5	47.5	54.0	57.2	63.9	82.6	116
Profit before tax	100	124	177	193	236	342	447	422
Tax	34.7	29.8	44.2	48.7	58.2	86.0	114	107
Tax rate %	34.6%	24.2%	25.0%	25.3%	24.7%	25.2%	25.5%	25.3%
Net profit	65.4	95.9	136	147	179	258	339	321
Profit to shareholders	0.0	0.0	—	—	179	258	339	322
Net margin %	0.0%	0.0%	17.3%	15.9%	16.1%	18.8%	20.3%	17.2%
EPS (₹)	7.41	10.86	15.24	15.27	18.67	26.90	34.11	31.75

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

1,2421467.1

Mar 23

1,47017012.1

Mar 24

2,7661788.7

Mar 25

3,10634251.2

Mar 26

3,26538658.2

Sep 26

Shareholders' equity · YoY (vs a year ago)

—+18%+88%+12%—

Shareholders' equityBorrowingsCashLine = trend

₹ Cr	Mar 23	Mar 24	Mar 25	Mar 26	Sep 26
Shareholders' equity	1,242	1,470	2,766	3,106	3,265
Long-term borrowings	17.5	1.1	0.0	52.1	39.1
Short-term borrowings	129	169	178	290	346
Total borrowings	146	170	178	342	386
Current liabilities	293	351	370	576	649
Fixed assets (PPE)	587	819	1,038	1,255	1,350
Inventories	209	221	286	434	512
Trade receivables	235	270	350	531	559
Cash & equivalents	7.1	12.1	8.7	51.2	58.2
Current assets	807	842	1,917	1,942	2,033
Total assets	1,577	1,859	3,192	3,919	4,155
Debt / equity	0.12	0.12	0.06	0.11	0.12

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

123-85.3-35.3

FY22

191-179-12.5

FY23

266-241-20.2

FY24

241-1,191953

FY25

241-22520.2

FY26

Operations · YoY (vs a year ago)

—+55%+39%-9.4%-0.2%

OperationsInvestingFinancingLine = trend

₹ Cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	123	191	266	241	241
Cash from investing	-85.3	-179	-241	-1,191	-225
Cash from financing	-35.3	-12.5	-20.2	953	20.2
Spent on fixed assets	-156	-239	-277	-325	-308
Free cash flow	-32.1	-48.4	-10.9	-83.9	-67.7
Net cash flow	2.8	-0.7	5.0	2.8	35.5

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

53.2%Mar 24

66.0%Jun 24

62.6%Aug 24

62.6%Sep 24

62.4%Dec 24

62.4%Mar 25

62.4%Jun 25

62.4%Sep 25

62.4%Dec 25

62.4%Mar 26

62.4%Jun 26

62.4%Sep 26

Promoter & groupPublic

Latest (30 Sep 2026)

62.4%promoter

Promoter & group: 62.42%
Public (FIIs, mutual funds, retail…): 37.58%
Promoter change, last quarter: 0.00 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

Dividend - Rs 3.50 Per ShareEx 28-Aug-2026
Dividend - Rs 3.50 Per ShareEx 18-Sep-2025
Annual General Meeting/Dividend - Rs 3 Per ShareEx 19-Sep-2024
Annual General Meeting/Dividend - Rs 3 Per ShareEx 21-Sep-2023
Annual General Meeting/Dividend - Rs 2.50 Per ShareEx 16-Sep-2022
Annual General MeetingEx 16-Sep-2021
Dividend - Rs 2.50 Per ShareEx 16-Sep-2021
Annual General MeetingEx 21-Sep-2020

Board meetings

POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financ…05-Nov-2026
the financial results for the period ended September 30, 2026 and other business matters05-Nov-2026
POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financ…05-Nov-2026
POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2026 to inter-alia consider and approve the Unaudited Financ…07-Aug-2026
the financial results for the period ended Jun 30, 2026 and other business matters07-Aug-2026

Filings with NSE

Analysts/Institutional Investor Meet/Con. Call Updates11 Nov
Monitoring Agency Report7 Nov
Copy of Newspaper Publication6 Nov
Analysts/Institutional Investor Meet/Con. Call Updates5 Nov
Updates5 Nov
Statement of deviation(s) or variation(s) under Reg. 325 Nov
Investor Presentation5 Nov

Latest news

Poly Medicure (NSEI:POLYMED) Stock Forecast & Analyst PredictionsSimply Wall St · 9 Nov, 1:30 pm Poly Medicure shares down 15% in three sessions after Q4 results; Here's what the management saidCNBC TV18 · 27 May, 12:30 pm Poly Medicure FY26 revenue rises 12.3%; net profit declines 5.3%scanx.trade · 25 May, 3:57 pm Ramco Cements, BEML, Poly Medicure shares surge amid spike in volumes; check full listUpstox · 10 Aug, 12:30 pm Poly Medicure Share Price Today Falls 5.35% on Key MetricsUnivest · 21 Oct, 12:30 pm Poly Medicure shares slide 5% after Q4 net profit drops 28%; declares ₹3.5 dividendCNBC TV18 · 25 May, 12:30 pm Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth WatchingSimply Wall St · 26 May, 12:30 pm POLYMED Share Price Today - Poly Medicure Stock AnalysisEquitypandit · 4 Sep, 2:39 pm

About

About Poly Medicure Limited

Poly Medicure Limited is listed on the NSE under the symbol POLYMED and belongs to the Healthcare sector.

Company details

Company name: Poly Medicure Limited
NSE symbol: POLYMED
BSE scrip code: 531768
ISIN: INE205C01021
Listed on: NSE, BSE, MSEI
Series: EQ (normal equity)
Listed on NSE since: 7 Dec 2011
Face value: ₹5 per share
Market lot: 1 share
Shares issued: 10.14 crore
Index: NIFTY 500
Sector (NSE): Healthcare
Industry: Medical Specialties
Managing director / CEO: Himanshu Baid
Chair: Devendra Raj Mehta
Headquarters: New Delhi, IN
Registered address: 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020, INDIA
Founded: 1995
Employees: 2,614
Financial year: April to March
Results basis: Consolidated
Website: polymedicure.com

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

Poly Medicure Limited

Today

Ratios

Quarterly results

Revenue and net profit

Profit & loss

Sales, operating profit and net profit

Balance sheet

Equity, debt and assets

Cash flow

Operating, investing and financing cash

Shareholding

Holding over time

Latest (30 Sep 2026)

Dividends & news

Dividends & corporate actions

Board meetings

Filings with NSE

Latest news

About

Company details

Peers